Assistant Professor

Radiation Oncology

Dr. Heath D. Skinner, MD

Heath D. Skinner, MD works in the field of Radiation Oncology. He studied medicine at West Virginia University School of Medicine. Dr. Heath D. Skinner is a published doctor. He has 49 papers published. The most current publication "Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer." He is registered with Medicare and accepts Medicare payments.

Publications

The Influence of Diabetes Mellitus and Metformin on Distant Metastases in Oropharyngeal Cancer: A Multicenter Study.
Salvage total laryngectomy after external-beam radiotherapy: A 20-year experience.
Association of Body Composition With Survival and Locoregional Control of Radiotherapy-Treated Head and Neck Squamous Cell Carcinoma.
Everything Old Is New Again: Using Nelfinavir to Radiosensitize Rectal Cancer.
Wee-1 Kinase Inhibition Sensitizes High-Risk HPV+ HNSCC to Apoptosis Accompanied by Downregulation of MCl-1 and XIAP Antiapoptotic Proteins.
Distribution of Resistant Esophageal Adenocarcinoma in the Resected Specimens of Clinical Stage III Patients after Chemoradiation: Its Clinical Implications.
Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.
Geographic Distribution of Regional Metastatic Nodes Affects the Outcome of Trimodality-Eligible Patients with Esophageal Adenocarcinoma.
Pre-Radiation Therapy Fluorine 18 Fluorodeoxyglucose PET Helps Identify Patients with Esophageal Cancer at High Risk for Radiation Pneumonitis.
Evolutionary Action Score of TP53 Identifies High-Risk Mutations Associated with Decreased Survival and Increased Distant Metastases in Head and Neck Cancer.
A validated miRNA profile predicts response to therapy in esophageal adenocarcinoma.
Inflammation-related genetic variants predict toxicity following definitive radiotherapy for lung cancer.
Inhibition of EGFR or IGF-1R signaling enhances radiation response in head and neck cancer models but concurrent inhibition has no added benefit.
The ability of bilirubin in identifying smokers with higher risk of lung cancer: a large cohort study in conjunction with global metabolomic profiling.
Importance of Surveillance and Success of Salvage Strategies After Definitive Chemoradiation in Patients With Esophageal Cancer.
Metformin sensitizes chemotherapy by targeting cancer stem cells and the mTOR pathway in esophageal cancer.
Association between metformin use and improved survival in patients with laryngeal squamous cell carcinoma.
The impact of race on oropharyngeal squamous cell carcinoma presentation and outcomes among veterans.
Gain-of-Function Mutant p53 Promotes Cell Growth and Cancer Cell Metabolism via Inhibition of AMPK Activation.
Reply to R. Gertler et al.
Risk of late toxicity in men receiving dose-escalated hypofractionated intensity modulated prostate radiation therapy: results from a randomized trial.
Chemoradiation for esophageal cancer.
ALDH-1 expression levels predict response or resistance to preoperative chemoradiation in resectable esophageal cancer patients.
Locoregional Failure Rate After Preoperative Chemoradiation of Esophageal Adenocarcinoma and the Outcomes of Salvage Strategies.
Incidence of Brain Metastases after Trimodality Therapy in Patients with Esophageal or Gastroesophageal Cancer: Implications for Screening and Surveillance.
Integration of cancer genomics with treatment selection: From the genome to predictive biomarkers.
Propensity-Based Matching between Esophagogastric Cancer Patients Who Had Surgery and Who Declined Surgery after Preoperative Chemoradiation.
Clinical characteristics of patients with multiple potentially HPV-related malignancies.
Impact of race/ethnicity on laryngeal cancer in patients treated at a Veterans Affairs Medical Center.
Improving Imaging Diagnosis of Persistent Nodal Metastases after Definitive Therapy for Oropharyngeal Carcinoma: Specific Signs for CT and Best Performance of Combined...
Metformin use and improved response to therapy in rectal cancer.
Radiation dose escalation for loco-regional recurrence of breast cancer after mastectomy.
Residual nodal disease in patients with advanced-stage oropharyngeal squamous cell carcinoma treated with definitive radiation therapy and posttreatment neck dissectio...
Glycolytic inhibition alters anaplastic thyroid carcinoma tumor metabolism and improves response to conventional chemotherapy and radiation.
TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.
Radiation treatment outcomes for unresectable hepatocellular carcinoma.
Charged-particle therapy for hepatocellular carcinoma.
Individualizing antimetabolic treatment strategies for head and neck squamous cell carcinoma based on TP53 mutational status.
Outcomes of malignant tumors of the lacrimal apparatus: The University of Texas MD Anderson Cancer Center experience.
Outcomes of malignant tumors of the lacrimal apparatus: the University of Texas M. D. Anderson Cancer Center experience.
An algorithm for identifying novel targets of transcription factor families: application to hypoxia-inducible factor 1 targets.
Mechanism of vascular endothelial growth factor expression mediated by cisplatin in human ovarian cancer cells.
Vascular endothelial growth factor transcriptional activation is mediated by hypoxia-inducible factor 1alpha, HDM2, and p70S6K1 in response to phosphatidylinositol 3-k...
Arsenite induces p70S6K1 activation and HIF-1alpha expression in prostate cancer cells.
Reactive oxygen species and p21(Waf1/Cip1) are both essential for p53-mediated senescence of head and neck cancer cells.
Use of biguanides to improve response to chemotherapy.
Evaluating Response to Metformin/Cisplatin Combination in Cancer Cells via Metabolic Measurement and Clonogenic Survival.
Evaluation of hyperpolarized [1-(13)c]-pyruvate by magnetic resonance to detect ionizing radiation effects in real time.

Schools

West Virginia University

Doctors Specialties

Radiation Oncology

Accepted Insurances

Aetna HMO
Choice Plus POS II
Blue Card PPO
Blue Choice
Cigna HMO
Cigna PPO
Great West Healthcare-Cigna PPO
LocalPlus
Open Access Plus
Choice Care PPO
MHealth Insured
MultiPlan PPO
PHCS Network PPO
Choice Plus POS
Navigate HMO
Navigate POS
Options PPO

Education

University of Texas MD Anderson Cancer Center
West Virginia University School of Medicine

Drug Facts

NPI NUMBER		1194095455
NPPES Provider LastName		SKINNER
NPPES Provider FirstName		HEATH
NPPES Provider ZIPCode		770304009
NPPES Provider State		TX
Specialty Description		Radiation Oncology
Total Claim Count		55.0
Distinct Opioid Count		1.0
Opioid Claim Count		20.0
Percent Opioid Claims		36.36

Helpful Reviews

Give Anonymous Review

Medicare Facts

National Provider Identifier [NPI]	1194095455
Last Name Of The Provider	SKINNER
First Name Of The Provider	HEATH
View All

Similar Doctors

	Dr. Neil E. Sherman, MD
	Dr. Seungtaek Choi, MD This Doctor is OpenDoctor Recommended.
	Dr. Gary R. Leach, MD This Doctor is OpenDoctor Recommended.
	Dr. Jing Li, MD This Doctor is OpenDoctor Recommended.
	Dr. Howard Moench, MD This Doctor is OpenDoctor Recommended.
	Dr. Bouthaina S. Dabaja, MD This Doctor is OpenDoctor Recommended.
	Dr. Ali Mazloom, MD This Doctor is OpenDoctor Recommended.
	Dr. Edward B. Butler, MD This Doctor is OpenDoctor Recommended.
	Dr. Sean R. Quinlan-Davidson, MD
	Dr. Jonathan Verma, MD This Doctor is OpenDoctor Recommended.